Biotech News
-
Zentek Receives Approval for Nasdaq Listing
March 7, 2022 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian IP development and…
-
Hemostemix: Interest Payment on Convertible Debenture
March 3, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased…
-
Hemostemix Announces $2,750,000 Convertible Debenture
March 2, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased to…
-
Hemostemix Announces Stock Options Grant
March 1, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased…
-
Sixth Wave Innovations Inc. “Green Lixiviant for Gold Mining” Research Program Confirms Non-Toxicity with Superb Gold Recovery
March 1, 2022 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (the “Company” or “Sixth Wave”)…
-
Valeo Pharma Reports Record Annual Revenues for Fiscal 2021
February 28, 2022 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Hemostemix Announces Closing of UNIT Private Placement
February 28, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) announces that it…
-
Zentek Provides Corporate Update
November 11, 2021 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, IP development and…
-
Valeo Pharma Obtains Public Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler® in Ontario, Manitoba and New Brunswick
Atectura and Enerzair also now reimbursed by the Non-Insured Health Benefits (“NIHB”) program of Indigenous Services Canada and Veteran…
-
Voyageur Pharmaceuticals Announces Shareholder Update and Filing of Frances Creek Preliminary Economic Assessment Report
February 24, 2022 (Source) — Voyageur Pharmaceuticals Ltd. (“Voyageur” or the “Company”) (TSXV:VM) (OTC:VYYRF) is pleased to announce the filing of…
